Hematology/Oncology
Volumes and Outcomes
The Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta is a national leader among childhood cancer, hematology, and blood and marrow transplant programs, treating more than 350 new cancer patients per year and following more than 2,500 patients with sickle cell disease, hemophilia and other blood disorders. In 2008, the Aflac Cancer Center performed 58 blood and marrow transplants and is now able to transplant an increasing number of pediatric patients with cancer, as well as others with a variety of non-malignant but life-threatening diseases such as sickle cell disease. The Aflac Cancer Center is especially proud of our impact on the cure and the overall survival rates of our patients.
Cancer
Return to top
Return to top
Blood Disorders
Return to top
Return to top
Blood and Marrow Transplant
Return to top
Return to top
Return to top
Return to top
Return to top
Return to top
Research
Return to top
Return to top
Historical survival rate data is not an indicator of the likelihood of future successful treatment in any particular patient. Future survival rates may vary.
Some physicians and affiliated healthcare professionals who perform services at Children's Healthcare of Atlanta are independent providers and are not hospital employees.